Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
680.00    -5.00 (-0.73%)
Bid:
680.00
Ask:
682.00
Spread: 2.00 (0.294%)
Market Cap: £660.42m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Interim Management Statement

23 Jan 2009 07:00

RNS Number : 1292M
Acal PLC
23 January 2009
 



FOR RELEASE

7.00 AM

23 JANUARY 2009

ACAL plc 

SECOND INTERIM MANAGEMENT STATEMENT

PERIOD COMMENCING 1 OCTOBER 2008

Acal plc is today issuing its second Interim Management Statement for the year ending 31 March 2009, which covers the period commencing 1 October 2008 to date and includes trading for the nine months ended 31 December 2008.

Current trading

As we have reported in earlier statements, our markets have become increasingly difficult over the last six months.

Although the Group's sales for the quarter ended 31 December 2008 were slightly ahead of the corresponding quarter to December 2007, margins within the Electronics Division were adversely impacted by the decline in sterling over the quarter.  Within the Supply Chain Division (formerly Parts Services), the new management team has commenced the integration of Service Source Europe and is working to resolve ongoing contract operating losses.

In light of current trading levels, one-off foreign exchange losses and the cost of implementing further efficiencies, the Group result for the year ending 31 March 2009 will be below market expectations.

Following the net benefit from the sale of MessageLabs Group and the acquisition of Service Source Europe Limited, the group retains significant net cash despite increasing pressures on working capital. 

With the appointment of Nick Jefferies as Group Chief Executive on 5 January 2009, we will be carrying out a comprehensive review of Acal's business and strategy. The Board remains confident in the opportunities for the development of the business.

The following material events or transactionseach of which has been previously reported, impacted the Group during the period covered by this Interim Management Statement.

MessageLabs Group Limited

The sale of MessageLabs Group Limited to Symantec was completed on 14 November 2008. The total consideration receivable by Acal for its 3.95% investment is £16.2 million of which £15.1 million was received on that date. The balance is retained in escrow and will be returned to Acal if there are no warranty claims within a 12 month period.

Service Source Europe Limited

The acquisition of 75% of Service Source Europe Limited (SSE) was completed on January 9 2009 for a consideration in cash of £1.85 million. In addition, Acal subscribed for deferred shares in SSE with a total nominal value of £346,625 in cash to enable SSE's preference shares to be redeemed.

  

For further information:-

Nicholas Jefferies ~ Chief Executive

Malcolm Cooper ~ Finance Director

Brian Coleman-Smith/James Verstringhe

Cubitt Consulting 

01483 544500

01483 544500

020 7367 5100

Notes to the Interim Management Statement

(a) This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Acal plc, as a body, in order to meet the requirements of the UK Listing Authority’s Disclosure and Transparency Rules.
 
(b) The Interim Management Statement may contain forward-looking statements which:

 

§ have been made by the directors in good faith based on the information available to them up to the time of their approval of this statement; and
 
§ should be treated with caution due to inherent uncertainties, which are beyond Acal’s ability to control or estimate precisely and include both economic and business risk factors, underlying such forward looking information.

Notes to Editors:

Acal is a leading European value-added distributor providing specialist design-in, sales and marketing services for international suppliers in the fields of Electronic Components, Supply Chain Services and Medical and Scientific products. Organised into three divisions, Acal has 15 principal trading companies of which 8 are in Continental Europe and 7 in the UK.

Acal is now Europe's strongest multi-disciplined design-in electronics distributor and has always differentiated its offering with a strong focus on demand creation and a highly skilled technical sales force. Vertec Scientific, which operates in both the UK and South Africa, represents leading manufacturers in the field of bone densitometry, medical imaging and diagnostics. The Supply Chain division provides spare parts to field services organisations and is a supplier to virtually every leading company in that market. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBCGDBXGDGGCD
Date   Source Headline
13th Oct 20167:00 amRNSTrading Update
12th Aug 20161:54 pmRNSHolding(s) in Company
10th Aug 20162:08 pmRNSHolding(s) in Company
26th Jul 201612:13 pmRNSResult of AGM
26th Jul 20167:00 amRNSTrading Statement
20th Jul 20169:44 amRNSHolding(s) in Company
7th Jul 20167:00 amRNSNotice of Trading Update
17th Jun 20169:00 amRNSEXERCISE OF SHARE OPTION
17th Jun 20167:00 amRNSAnnual Report and Accounts
1st Jun 20167:00 amRNSFinal Results
18th Apr 20165:35 pmRNSHolding(s) in Company
15th Apr 20167:00 amRNSTrading Update
23rd Mar 201611:32 amRNSHolding(s) in Company
12th Feb 20167:00 amRNSTrading Update & Acquisition
3rd Feb 20169:37 amRNSDirector Declaration
18th Jan 20167:00 amRNSEXERCISE OF SHARE OPTIONS
11th Jan 20167:00 amRNSAdditional Listing
8th Jan 20167:00 amRNSAcquisition
21st Dec 20157:00 amRNSExercise of Share Options
2nd Dec 201510:53 amRNSDirector/PDMR Shareholding
30th Nov 20157:00 amRNSHalf Yearly Report
6th Nov 20157:00 amRNSAcquisition
29th Oct 20157:00 amRNSBoard Appointments
15th Oct 20157:00 amRNSTrading Update
29th Jul 201512:58 pmRNSResult of AGM
29th Jul 20157:00 amRNSTrading Update
30th Jun 20157:00 amRNSExercise of Share Options
26th Jun 20151:06 pmRNSAnnual Report and Accounts
24th Jun 20153:09 pmRNSHolding(s) in Company
22nd Jun 201510:11 amRNSHolding(s) in Company
19th Jun 20153:59 pmRNSHolding(s) in Company
19th Jun 201511:48 amRNSHolding(s) in Company
17th Jun 20157:00 amRNSNotice of Site Visit
16th Jun 20157:00 amRNSDirectorate Change
4th Jun 201511:28 amRNSRe: Dividend
2nd Jun 20154:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20157:00 amRNSFinal Results
17th Apr 20157:01 amRNSAppointment of New Chairman
17th Apr 20157:00 amRNSTrading Update
12th Mar 20155:52 pmRNSHolding(s) in Company
23rd Feb 20157:00 amRNSBoard Appointment
9th Feb 20157:00 amRNSInterim Management Statement
27th Jan 201512:57 pmRNSHolding(s) in Company
7th Jan 20157:00 amRNSAcquisition
29th Dec 20147:00 amRNSHolding(s) in Company
27th Nov 20147:00 amRNSHalf Yearly Report
19th Nov 20144:17 pmRNSHolding(s) in Company
13th Nov 201410:48 amRNSNotification of Major Interest in Shares
11th Nov 20143:30 pmRNSHolding(s) in Company
6th Nov 20147:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.